Discontinuation report MYLAN-ALPRAZOLAM
| Report ID | 20290 |
| Drug Identification Number | 02137534 |
| Brand name | MYLAN-ALPRAZOLAM |
| Common or Proper name | ALPRAZOLAM |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ALPRAZOLAM |
| Strength(s) | 0.25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BT, 1000BT |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-12-01 |
| Actual discontinuation date | 2017-12-01 |
| Remaining supply date | 2017-12-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-08-24 | English | Compare |
| v2 | 2017-08-24 | French | Compare |
| v3 | 2017-08-31 | English | Compare |
| v4 | 2017-08-31 | French | Compare |
| v5 | 2017-08-31 | English | Compare |
| v6 | 2017-08-31 | French | Compare |
| v7 | 2017-10-23 | English | Compare |
| v8 | 2017-10-23 | French | Compare |
| v9 | 2017-12-01 | English | Compare |
| v10 | 2017-12-01 | French | Compare |
| v11 | 2017-12-01 | English | Compare |
| v12 | 2017-12-01 | French | Compare |
| v13 | 2017-12-01 | English | Compare |
| v14 | 2017-12-01 | French | Compare |
| v15 | 2017-12-02 | English | Compare |
Showing 1 to 15 of 15